Latest Trading Suspension News

Smartpay Holdings has secured final court approval for its acquisition by Shift4 Holdings, setting the stage for share suspension and delisting in early November. Shareholders will receive NZ$1.20 per share in cash upon completion, pending final conditions.

ASF Group Limited has voluntarily suspended trading of its securities on the ASX pending a response to regulatory queries, signaling heightened scrutiny and market uncertainty.

Corporate Travel Management reports a 6% revenue increase and a 29% rise in EBITDA for 1QFY26, maintaining operational strength amid an ongoing audit review and trading suspension.

Trading in Australian Oil Company Limited shares has resumed following the lifting of a suspension tied to a recent capital raising announcement.

Australian Oil Company Limited has voluntarily suspended trading on the ASX as it finalizes a capital raising deal, with details expected by 24 October 2025.

Tigers Realm Coal's planned sale of its Russian subsidiaries faces ongoing delays due to regulatory hurdles and buyer demands for further price cuts, leaving the transaction in limbo and the company suspended from ASX trading.

Scout Security has raised a further $220,000 through a share placement, bringing total capital raised to $820,000, as it works toward resolving its trading suspension.

Vectus Biosystems has had its ASX trading suspension lifted following the disclosure of a significant transaction involving a compound from its drug library, signaling renewed investor interest.

Vectus Biosystems has requested an immediate suspension of its ASX-listed shares pending a significant announcement about a transaction involving a compound in its drug library.

Hawk Resources Limited has had its trading suspension lifted immediately following a significant announcement about an acquisition and capital raising, signaling renewed momentum for the mining company.

TrivarX Limited has resumed trading on the ASX following the announcement of a significant acquisition and a fresh capital raising, signaling a pivotal moment for the biotech company.

The ASX has released its latest list of entities suspended from trading for over three months, highlighting looming deadlines for report submissions and potential removal from the official list.